Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cengiz

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 17, 2008
Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancerY Kucukzeybek, G Gorumlu, B Karaca, et al.
Cell Biology International|September 1, 2009
Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combinationU A Sanli, G Gorumlu, C Erten, et al.
Cell Biology International|December 24, 2008
Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cellsB Karabulut, C Erten, M K Gul, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 17, 2008
Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancerY Kucukzeybek, G Gorumlu, B Karaca, et al.
Cell Biology International|September 1, 2009
Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combinationU A Sanli, G Gorumlu, C Erten, et al.
Cell Biology International|December 24, 2008
Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cellsB Karabulut, C Erten, M K Gul, et al.
Pageof 2